Get the Stockscreener App
373.82
2.35%
9.35
Evercore Inc stock is traded at $373.82, with a volume of 323.21K.
It is up +2.35% in the last 24 hours and up +12.46% over the past month.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.
See More
Previous Close:
$364.47
Open:
$363.42
24h Volume:
323.21K
Relative Volume:
0.88
Market Cap:
$14.44B
Revenue:
$3.26B
Net Income/Loss:
$503.61M
P/E Ratio:
34.00
EPS:
10.9949
Net Cash Flow:
$718.54M
1W Performance:
+8.55%
1M Performance:
+12.46%
6M Performance:
+29.75%
1Y Performance:
+33.77%
1-Day Range:
$356.19
$375.05
1-Week Range:
$338.95
$375.05
52-Week Range:
$148.63
$375.05
Evercore Inc Stock (EVR) Company Profile
Name
Evercore Inc
Sector
Industry
Phone
212-857-3100
Address
55 EAST 52ND STREET, NEW YORK, NY
Compare EVR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
373.36 | 14.10B | 3.26B | 503.61M | 718.54M | 10.99 |
|
MS
Morgan Stanley
|
187.80 | 296.47B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
955.51 | 284.46B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
103.83 | 184.34B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
121.90 | 110.82B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
IBKR
Interactive Brokers Group Inc
|
72.86 | 31.87B | 10.12B | 4.13B | 27.25B | 2.0757 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Resumed | UBS | Neutral |
| Dec-08-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-09-25 | Initiated | Deutsche Bank | Buy |
| Oct-03-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-14-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jun-23-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-08-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Apr-07-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-20-24 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Sep-12-24 | Initiated | Wells Fargo | Equal Weight |
| Sep-11-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-29-24 | Resumed | Keefe Bruyette | Mkt Perform |
| Jan-09-24 | Downgrade | UBS | Buy → Neutral |
| Aug-22-23 | Downgrade | Goldman | Buy → Neutral |
| Apr-12-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-12-23 | Upgrade | UBS | Sell → Buy |
| Jan-11-23 | Upgrade | Goldman | Neutral → Buy |
| Oct-27-22 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-23-22 | Downgrade | UBS | Neutral → Sell |
| Jan-06-22 | Downgrade | Goldman | Buy → Neutral |
| Dec-08-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-04-21 | Downgrade | UBS | Buy → Neutral |
| Apr-09-21 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Mar-19-21 | Reiterated | Goldman | Buy |
| Jan-05-21 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-16-20 | Initiated | Seaport Global Securities | Buy |
| Dec-01-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Oct-02-20 | Upgrade | UBS | Neutral → Buy |
| Aug-05-20 | Upgrade | Goldman | Neutral → Buy |
| Jul-09-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-25-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-06-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Nov-20-19 | Initiated | Morgan Stanley | Overweight |
| Aug-14-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-06-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-23-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jan-07-19 | Downgrade | Goldman | Neutral → Sell |
| Nov-06-18 | Initiated | Goldman | Neutral |
| Jan-09-18 | Upgrade | UBS | Neutral → Buy |
| May-23-17 | Downgrade | Goldman | Buy → Neutral |
| Mar-27-17 | Initiated | Keefe Bruyette | Mkt Perform |
| Feb-16-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-13-17 | Downgrade | Instinet | Buy → Neutral |
| Dec-14-16 | Initiated | BofA/Merrill | Neutral |
| Nov-21-16 | Resumed | Credit Suisse | Outperform |
View All
Evercore Inc Stock (EVR) Latest News
UnitedHealth wins outperform at Evercore despite elevated utilization trends - MSN
Canadian Natural Resources (TSE:CNQ) Stock Rating Lowered by Evercore Partners - MarketBeat
Guardant Health stock jumps 7% as Evercore downgrades — what investors watch next - ts2.tech
Evercore ISI downgrades MetLife, cites rich valuation - TradingView — Track All Markets
Fortrea upgraded at Evercore ISI on new CEO (FTRE:NASDAQ) - Seeking Alpha
Evercore ISI Adjusts Price Target on Fifth Third Bancorp to $52 From $47, Maintains In Line Rating - marketscreener.com
UnitedHealth wins Outperform rating at Evercore ISI (UNH:NYSE) - Seeking Alpha
Evercore ISI Adjusts Price Target on U.S. Bancorp to $60 From $53, Maintains In Line Rating - marketscreener.com
TFC Upgrade: Evercore ISI Group Raises Price Target to $58 | TFC Stock News - GuruFocus
Zions Bancorporation, N.A. (NASDAQ:ZION) Receives In-Line Rating from Evercore ISI - MarketBeat
Truist Financial (NYSE:TFC) Upgraded to Outperform at Evercore ISI - MarketBeat
MTB Stock Sees Downgrade and Raised Price Target by Evercore ISI - GuruFocus
ALLY Stock Upgraded to Outperform by Evercore ISI Group | ALLY S - GuruFocus
BP Downgraded by Evercore ISI Group to In-Line Rating | BP Stock News - GuruFocus
Pinnacle Financial Partners (NASDAQ:PNFP) Coverage Initiated at Evercore ISI - MarketBeat
Evercore ISI Upgrades Ally Financial (ALLY) Amid Positive Outloo - GuruFocus
Evercore ISI shifts oil stock ratings as SLB upgraded and peers cut - Investing.com Canada
Ally Financial, Truist upgraded, M&T Bank, Zions, Regions cut at Evercore (ALLY:NYSE) - Seeking Alpha
Evercore ISI Adjusts Price Target on Wells Fargo to $110 From $107 - marketscreener.com
Evercore ISI Adjusts Price Target on Citizens Financial Group to $69 From $60, Maintains Outperform Rating - marketscreener.com
Evercore ISI initiates Pinnacle Financial with Buy-equivalent post Synovus acquisition (PNFP:NYSE) - Seeking Alpha
KeyCorp (NYSE:KEY) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
Evercore ISI Adjusts Price Target on Capital One Financial to $290 From $255, Maintains Outperform Rating - marketscreener.com
Baxter International (NYSE:BAX) Given New $23.00 Price Target at Evercore ISI - MarketBeat
Abbott Laboratories (NYSE:ABT) Given New $144.00 Price Target at Evercore ISI - MarketBeat
Evercore ISI Adjusts Price Target on Synchrony Financial to $97 From $86, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on American Express to $400 From $385, Maintains In Line Rating - marketscreener.com
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes - Investing.com UK
Canadian Natural Resources (NYSE:CNQ) Rating Lowered to In-Line at Evercore ISI - MarketBeat
Globe Life (NYSE:GL) Lowered to In-Line Rating by Evercore ISI - MarketBeat
Ally Financial (NYSE:ALLY) Upgraded at Evercore ISI - MarketBeat
Evercore ISI Upgrades Jackson Financial Incorporation to In Line From Underperform, Adjusts Price Target to $118 From $110 - marketscreener.com
Evercore ISI Upgrades Fortrea Holdings to Outperform From In Line, Adjusts Price Target to $25 From $14 - marketscreener.com
Bausch + Lomb (NYSE:BLCO) Rating Lowered to "Hold" at Evercore ISI - MarketBeat
Guardant Health (NASDAQ:GH) Stock Rating Lowered by Evercore ISI - MarketBeat
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Exact Sciences (NASDAQ:EXAS) Stock Rating Lowered by Evercore ISI - MarketBeat
Evercore ISI Downgrades M&T Bank to In Line From Outperform, Adjusts Price Target to $225 From $210 - marketscreener.com
Evercore ISI Downgrades Regions Financial to Underperform From In Line, Raises Price Target to $29 From $27 - marketscreener.com
Evercore ISI Upgrades Truist Financial to Outperform From In Line, Adjusts Price Target to $58 From $49 - marketscreener.com
Insurer Globe Life falls after Evercore ISI downgrades rating - TradingView — Track All Markets
Evercore ISI upgrades Ally Financial stock rating to Outperform By Investing.com - Investing.com UK
Evercore ISI Adjusts Price Target on Boston Scientific to $112 From $113, Maintains Outperform Rating - marketscreener.com
Evercore ISI Upgrades Agilent Technologies to Outperform From In Line, Adjusts PT to $160 From $155 - marketscreener.com
Evercore ISI initiates Pinnacle Financial stock with Outperform rating By Investing.com - Investing.com India
UnitedHealth Group stock rating initiated at Outperform by Evercore ISI - Investing.com India
Evercore ISI upgrades Fortrea stock to Outperform on biopharma cycle By Investing.com - Investing.com UK
Evercore ISI downgrades BP stock to In Line on CEO transition concerns - Investing.com Canada
Evercore ISI initiates Pinnacle Financial stock with Outperform rating - Investing.com
SLB stock rating upgraded by Evercore ISI on improved outlook - Investing.com UK
Evercore ISI Downgrades MetLife to In Line From Outperform, Adjusts PT to $97 From $108 - marketscreener.com
Evercore Inc Stock (EVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):